The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...

Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

Medtronic has received clearance from the U.S. Food and Drug Administration for the Simplera Sync sensor for use with the MiniMed 780G system.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration ...

The updated device allows users to pair the sensor with Medtronic’s insulin pumps, and is expected to grow the company’s ...

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Medtronic plc has announced the U.S. Food and Drug Administration (FDA) has approved the Simplera Sync sensor for use with ...

US FDA approves Medtronic’s new Simplera Sync sensor for the MiniMed 780G system: Galway, Ireland Monday, April 21, 2025, ...

Today, the MiniMed™ 780G system can be used with the Guardian™ 4 sensor. Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on ...

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced ...